Klinik Respirasi Malang Klinik Respirasi Malang Whatsapp Klinik Respirasi Malang Registrasi Klinik Respirasi malang Peta Lokasi Klinik
Galeri Foto
Berita Kesehatan

IL-6 trans-signalling: how Haemophilus surfs the NET to amplify inflammation in COPD

Holly R. Keir, James D. Chalmers

European Respiratory Journal 2021 58: 2102143; DOI: 10.1183/13993003.02143-2021


COPD is characterised by neutrophilic inflammation in the majority of patients [1–3]. Neutrophils represent a key second line of defence against infection and are rapidly recruited to the airway if pathogens are able to evade first line defences, which include mucociliary clearance and resident immune cells such as macrophages [3]. Neutrophils typically clear infection through ingestion of invading microbes (phagocytosis) and through the internal generation of reactive oxygen species, serine proteases such as neutrophil elastase, cathepsin G and proteinase-3, and antimicrobial proteins [4]. These processes aim to clear infection without damage to host tissues, but in COPD there is a failure of these normal antimicrobial processes. Mucociliary clearance is impaired, macrophage phagocytosis is less effective, and pro-inflammatory cytokines signal recruitment and survival of neutrophils which fail to effectively kill bacteria, leading to chronic neutrophilic inflammation and chronic infection [3–6]. Recent data suggests that a distinct form of neutrophil behaviour in which neutrophils release a DNA scaffold decorated with granule proteins (such as proteases) and termed neutrophil extracellular trap (NET) formation is associated with worse symptoms, frequent exacerbations and lung infections in a subset of patients [7–9]. The precise drivers and implications of NETosis in COPD are, however, unclear.

Haemophilus infection in COPD induces neutrophil extracellular traps which amplify inflammation through multiple mechanisms, including NET mediated IL-6 trans-signalling https://bit.ly/3yFI2b7


  • Conflict of interest: H.R. Keir has nothing to disclose.

  • Conflict of interest: J.D. Chalmers reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Insmed, Novartis and GlaxoSmithKline, personal fees from Chiesi, Janssen, Grifols and Zambon, grants from Gilead Sciences, outside the submitted work.

  • Received August 2, 2021.
  • Accepted August 6, 2021.

sumber : https://erj.ersjournals.com/content/58/4/2102143


RS Panti Waluya / RKZ Sawahan, Lt II-B1
, Dr Koentjahja, SpP
Nusakambangan 56, Malang 65117
08113777488 / 362017 ext. 88.23
Pukul 18.00 - 20.00, kec. Sabtu, Minggu / Libur

, Dr Koentjahja, SpP
Wilis Indah A-6, Malang 65115
0818568711 / 0341-568711
Senin - Sabtu Pukul 09.00-10.00,
kec. Minggu / Libur


Peta Lokasi

Update COVID-19 Malang
Jajak Pendapat

Apa saja gejala COVID-19?

Sakit Tenggorok
Sesak/Nyeri dada

 koentjahja.com  |
 nathaliamayasarisa.com  |
 klinikrespirasimalang.com  |
 drgevitaindiani.com  |
 drgleonyindriati.com  |